BR0010823A - Adjuvante de estabilidade, biocompatibilidade otimizada (sba) para realçar a resposta imune humoral e celular - Google Patents
Adjuvante de estabilidade, biocompatibilidade otimizada (sba) para realçar a resposta imune humoral e celularInfo
- Publication number
- BR0010823A BR0010823A BR0010823-5A BR0010823A BR0010823A BR 0010823 A BR0010823 A BR 0010823A BR 0010823 A BR0010823 A BR 0010823A BR 0010823 A BR0010823 A BR 0010823A
- Authority
- BR
- Brazil
- Prior art keywords
- sba
- immune response
- cellular immune
- humoral
- enhance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19923256 | 1999-05-20 | ||
PCT/EP2000/004565 WO2000071154A2 (de) | 1999-05-20 | 2000-05-19 | Stabilitäts-, biokompatibilitäts-optimiertes adjuvans (sba) zur erhöhung der humoralen und zellulären immunantwort |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010823A true BR0010823A (pt) | 2002-03-05 |
Family
ID=7908697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010823-5A BR0010823A (pt) | 1999-05-20 | 2000-05-19 | Adjuvante de estabilidade, biocompatibilidade otimizada (sba) para realçar a resposta imune humoral e celular |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1183045A2 (es) |
JP (1) | JP2003500365A (es) |
KR (1) | KR20020012221A (es) |
AU (2) | AU5214200A (es) |
BR (1) | BR0010823A (es) |
CA (1) | CA2373239A1 (es) |
DE (1) | DE10024788A1 (es) |
MX (1) | MXPA01011660A (es) |
TR (1) | TR200103333T2 (es) |
WO (2) | WO2000071154A2 (es) |
ZA (1) | ZA200109147B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020012221A (ko) * | 1999-05-20 | 2002-02-15 | 파르마솔 게엠베하 | 체액성 및 세포성 면역 반응을 증진시키기 위한, 안정성과생체 적합성이 최적화된 애쥬반트 |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
EP1675869B1 (en) * | 2003-10-23 | 2012-02-15 | Novartis Vaccines and Diagnostics, Inc. | Stabilised compositions |
FR2873386B1 (fr) | 2004-07-22 | 2011-01-14 | Agence Francaise De Securite Sanitaire Des Aliments Afssa | Composition vaccinale contre le rhodococcus equi |
DE602005024413D1 (de) | 2004-08-20 | 2010-12-09 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
ES2540886T3 (es) | 2004-08-23 | 2015-07-14 | Mannkind Corporation | Sales de dicetopiperazina para la administración de fármacos |
KR101557502B1 (ko) | 2005-09-14 | 2015-10-06 | 맨카인드 코포레이션 | 결정질 미립자 표면에 대한 활성제의 친화력의 증가를기반으로 하는 약물 제제의 방법 |
AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
PL2293833T3 (pl) | 2008-06-13 | 2016-08-31 | Mannkind Corp | Inhalator proszkowy i układ do dostarczania leku |
EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
EP2405963B1 (en) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
KR20180079458A (ko) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
US9016147B2 (en) | 2009-11-03 | 2015-04-28 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
CA2801936C (en) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Dry powder drug delivery system and methods |
EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
AU2013256565B2 (en) | 2012-04-30 | 2015-12-03 | Ossur Hf | Prosthetic device, system and method for increasing vacuum attachment |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
KR102499439B1 (ko) | 2013-03-15 | 2023-02-13 | 맨카인드 코포레이션 | 미세결정성 디케토피페라진 조성물 및 방법 |
MX2020009878A (es) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Composiciones farmaceuticas en polvo seco estables al calor y metodos. |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
US20180318415A1 (en) * | 2015-12-08 | 2018-11-08 | Glaxosmithkline Biologicals, Sa | Novel adjuvant formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19745950A1 (de) * | 1997-10-17 | 1999-04-22 | Dds Drug Delivery Service Ges | Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation |
JP2002521423A (ja) * | 1998-07-31 | 2002-07-16 | コリア インスティチュート オブ サイエンス アンド テクノロージ | 遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子 |
KR20020012221A (ko) * | 1999-05-20 | 2002-02-15 | 파르마솔 게엠베하 | 체액성 및 세포성 면역 반응을 증진시키기 위한, 안정성과생체 적합성이 최적화된 애쥬반트 |
-
2000
- 2000-05-19 KR KR1020017014653A patent/KR20020012221A/ko not_active Application Discontinuation
- 2000-05-19 EP EP00936761A patent/EP1183045A2/de not_active Withdrawn
- 2000-05-19 WO PCT/EP2000/004565 patent/WO2000071154A2/de not_active Application Discontinuation
- 2000-05-19 JP JP2000619456A patent/JP2003500365A/ja not_active Withdrawn
- 2000-05-19 DE DE10024788A patent/DE10024788A1/de not_active Ceased
- 2000-05-19 TR TR2001/03333T patent/TR200103333T2/xx unknown
- 2000-05-19 CA CA002373239A patent/CA2373239A1/en not_active Abandoned
- 2000-05-19 AU AU52142/00A patent/AU5214200A/en not_active Abandoned
- 2000-05-19 BR BR0010823-5A patent/BR0010823A/pt not_active IP Right Cessation
- 2000-05-19 MX MXPA01011660A patent/MXPA01011660A/es unknown
- 2000-05-22 AU AU58091/00A patent/AU5809100A/en not_active Abandoned
- 2000-05-22 WO PCT/EP2000/004644 patent/WO2000071077A2/en not_active Application Discontinuation
-
2001
- 2001-11-06 ZA ZA200109147A patent/ZA200109147B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20020012221A (ko) | 2002-02-15 |
WO2000071154A3 (de) | 2001-06-28 |
AU5214200A (en) | 2000-12-12 |
MXPA01011660A (es) | 2004-04-05 |
AU5809100A (en) | 2000-12-12 |
ZA200109147B (en) | 2002-05-08 |
CA2373239A1 (en) | 2000-11-30 |
DE10024788A1 (de) | 2000-11-23 |
TR200103333T2 (tr) | 2002-04-22 |
EP1183045A2 (de) | 2002-03-06 |
JP2003500365A (ja) | 2003-01-07 |
WO2000071077A2 (en) | 2000-11-30 |
WO2000071154A2 (de) | 2000-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0010823A (pt) | Adjuvante de estabilidade, biocompatibilidade otimizada (sba) para realçar a resposta imune humoral e celular | |
Masson et al. | Calcium phosphate: a substitute for aluminum adjuvants? | |
ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
ATE149841T1 (de) | Impfstoffe gegen krebs und infektionskrankheiten | |
DE69840962D1 (de) | Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel | |
HU9904549A (en) | Vaccines | |
ATE264691T1 (de) | Newcastle-krankheitsvirus-kombinationsimpfstoff | |
PT1135166E (pt) | Conjugados de hapteno-veiculo para o tratamento e prevencao da dependencia a nicotina | |
DK1140165T3 (da) | Fordbedrede adjuvanssammensætninger baseret på saponin og dermed tilhörende metoder | |
DE69939747D1 (de) | Verfahren von dna-impfung | |
ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
ATE501726T1 (de) | Zusammensetzung mit immunogenen mikroteilchen | |
DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
EP1964573A3 (en) | Method of inducing and/or enhancing an immune response to tumor antigens | |
DK0686030T3 (da) | Med antigen ladede mikropartikler og farmaceutiske sammensætninger, som indeholder disse mikropartikler | |
DE69828182D1 (de) | Polynukleotid-impfstoff-formulierungen | |
WO2000012122A3 (de) | Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen | |
BR9807332A (pt) | Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose | |
BRPI0409321A (pt) | antìgeno hìbrido, competição e método para induzir uma resposta imune para um agente infeccioso ou antìgeno de tumor, método para tratar uma doença infecciosa ou cáncer, e, peptìdeo | |
BR0303362A (pt) | Composição e método para melhorar uma resposta imune em um animal, método para distribuir uma proteìna de carga em uma célula de animal, célula viva geneticamente modificada, e, método para a construção de uma proteìna de fusão para melhorar a resposta imune em um animal | |
ATE505482T1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
ATE109004T1 (de) | Toleranzinduktion gegenüber einem fremdantigen. | |
BR0207020A (pt) | Fator de estimulação de colÈnia por granulócito (g-csf) modificado com imunogenicidade reduzida | |
DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |